These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6278886)

  • 1. In vivo and in vitro models of demyelinating diseases.
    Sorensen O; Coulter-Mackie M; Percy D; Dales S
    Adv Exp Med Biol; 1981; 142():271-86. PubMed ID: 6278886
    [No Abstract]   [Full Text] [Related]  

  • 2. Host and virus factors associated with CNS cellular tropism leading to encephalomyelitis or demyelination induced by the JHM strain of mouse hepatitis virus.
    Knobler RL; Haspel MV; Dubois-Dalcq M; Lampert PW; Oldstone MB
    Adv Exp Med Biol; 1981; 142():341-8. PubMed ID: 6278890
    [No Abstract]   [Full Text] [Related]  

  • 3. JHM infections in rats as a model for acute and subacute demyelinating disease.
    Wege H; Koga M; Wege H; ter Meulen V
    Adv Exp Med Biol; 1981; 142():327-40. PubMed ID: 6278889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro models of demyelinating disease, XXI: relationship between differentiation of rat oligodendrocytes and control of JHMV replication.
    Beushausen S; Dales S
    Adv Exp Med Biol; 1987; 218():239-54. PubMed ID: 2829533
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropathogenicity of mutant strains of mouse hepatitis virus, 1A and 2C, from DBT cells persistently infected with JHM strain.
    Goto N; Makino S; Fujiwara K
    Adv Exp Med Biol; 1987; 218():439-40. PubMed ID: 2829556
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo and in vitro models of demyelinating disease: efficiency of virus spread and formation of infectious centers among glial cells is genetically determined by the murine host.
    Wilson GA; Dales S
    J Virol; 1988 Sep; 62(9):3371-7. PubMed ID: 2841490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats.
    Sorensen O; Perry D; Dales S
    Arch Neurol; 1980 Aug; 37(8):478-84. PubMed ID: 6251790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of CNS virulence of MHV-4.
    Buchmeier MJ; Dalziel RG; Koolen MJ; Lampert PW
    Adv Exp Med Biol; 1987; 218():287-95. PubMed ID: 2829542
    [No Abstract]   [Full Text] [Related]  

  • 9. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.
    Lane TE; Buchmeier MJ
    Trends Microbiol; 1997 Jan; 5(1):9-14. PubMed ID: 9025229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro models of demyelinating diseases--VIII: Genetic, immunologic and cellular influences on JHM virus infection of rats.
    Sorensen O; Beushausen S; Puchalski S; Cheley S; Anderson R; Coulter-Mackie M; Dales S
    Adv Exp Med Biol; 1984; 173():279-98. PubMed ID: 6331119
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenicity and persistence of mouse hepatitis virus in inbred strains of mice.
    Virelizier JL
    Adv Exp Med Biol; 1981; 142():349-58. PubMed ID: 6278891
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.
    Sorensen O; Coulter-Mackie MB; Puchalski S; Dales S
    Virology; 1984 Sep; 137(2):347-57. PubMed ID: 6091333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus JHM induced demyelinating disease: specific domains on the E2-protein are associated with neurovirulence.
    Wege H; Winter J; Massa P; Dörries R; ter Meulen V
    Adv Exp Med Biol; 1987; 218():307-20. PubMed ID: 2449042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune mediated clearance of JHM virus from the central nervous system.
    Sussman MA; Fleming JO; Allen H; Stohlman SA
    Adv Exp Med Biol; 1987; 218():399-410. PubMed ID: 2829552
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo and in vitro models of demyelinating disease, XXIII: Infection by JHM virus of athymic rats.
    Sorensen O; Saravani A; Dales S
    Adv Exp Med Biol; 1987; 218():383-90. PubMed ID: 2829549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically-determined sensitivity to MHV3 infections is expressed in vitro in lymphoid cells and macrophages.
    Dupuy JM; Lamontagne L
    Adv Exp Med Biol; 1987; 218():455-63. PubMed ID: 2449044
    [No Abstract]   [Full Text] [Related]  

  • 17. Biology of coronaviruses 1983.
    ter Meulen V
    Adv Exp Med Biol; 1984; 173():227-35. PubMed ID: 6331113
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats.
    Watanabe R; Wege H; ter Meulen V
    Lab Invest; 1987 Oct; 57(4):375-84. PubMed ID: 2444766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus-induced CNS disease: a model for virus-induced demyelination.
    Buchmeier MJ; Dalziel RG; Koolen MJ
    J Neuroimmunol; 1988 Dec; 20(2-3):111-6. PubMed ID: 2848860
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo and in vitro models of demyelinating diseases, XX: Replication of coronaviruses in primary neural cultures from genetically resistant and susceptible mice.
    Wilson GA; Dales S
    Adv Exp Med Biol; 1987; 218():223-30. PubMed ID: 2829531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.